Purchases and Sales Made in Q2 2024 in Vaneck ETF Tr Vaneck Pharmaceu (PPH)
This table provides information about the institutional ownership of Vaneck ETF Tr Vaneck Pharmaceu (PPH) during Q2 2024. The information is specifically focused on institutions that hold shares of VANECK ETF TR VANECK PHARMACEU.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-24.6K- 23.49% |
$2.09M - $2.29M
|
80.1K
$6.93M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-24.6K- 23.49% |
$2.09M - $2.29M
|
80.1K
$6.93M
|
|
|
Aug 14, 2024
Q2 2024
|
Kingsview Wealth Management, LLC
Grants Pass, OR |
SELL
|
- |
-25.3K- 83.88% |
$2.15M - $2.36M
|
4.87K
$421K
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-26.2K- 75.13% |
$2.22M - $2.44M
|
8.68K
$751K
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-319K- 78.02% |
$27.1M - $29.7M
|
89.8K
$7.78M
|